Home Tags 7MW3711

Tag: 7MW3711

Risvutatug Rezetecan Demonstrates Overall Survival Benefit Over Topotecan in Relapsed Small...

Interim results from the pivotal Phase 3 ARTEMIS-008 trial (NCT06498479) show that risvutatug rezetecan, a B7-H3-directed antibody-drug conjugate, significantly reduced the risk of death...
Featured Image: Journal + glasses. Courtesy: © 2017 - 2019. Fotolia. Used with permission.

The Roundup: July 2024

The Roundup: July 2024